Regional distribution and in vivo binding of the atypical antipsychotic drug remoxipride. A biochemical and autoradiographic analysis in the rat brain
- 1 February 1992
- journal article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 87 (1) , 49-62
- https://doi.org/10.1007/bf01253110
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- RemoxiprideDrugs, 1990
- Biochemical pharmacology of the atypical neuroleptic remoxiprideActa Psychiatrica Scandinavica, 1990
- Neuropharmacological and behavioural properties of remoxipride in the ratActa Psychiatrica Scandinavica, 1990
- Atypical antipsychotics—recent findings and new perspectivesMedicinal Research Reviews, 1988
- In vivo labelling of rat brain dopamine D-2 receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: Evidence for selective labelling of dopamine receptorsEuropean Journal of Pharmacology, 1986
- Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brainEuropean Journal of Pharmacology, 1984
- Regional blockade by neuroleptic drugs ofin vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypiesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptorsEuropean Journal of Pharmacology, 1981
- Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spiroperidol in the rat pituitary and striatum with in vivo effects on rat prolactin secretionLife Sciences, 1979